ROCHE-WA17042

Study Sponsor : Roche

Study Title

A Phase IIb Randomized, Multifactorial, Double-Blind, Parallel Group, Dose Ranging Study of the Efficacy and Safety of Rituximab (MabThera/Rituxan) in Combination with Methotrexate, in Patients with active Rheumatoid Arthritis

Medicine or Vaccine (generic name)

rituximab

Sponsor Identification Number

WA17042

Trial Registry Identification Number(#'s)

NCT00468546

Medical Condition

rheumatoid arthritis

Phase

Phase 3

Link to study details on the Roche Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT00468546?term=WA17042&rank=2

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

October 2015